Advanced Biomarker Assessment in Pelvic Organ Prolapse

NCT03642054 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2021-09-24

No results posted yet for this study

Summary

This study will assess advanced biomarkers in patients with and without vaginal prolapse. Assessments will be directed at vaginal fibroblasts and adipose derived stem cells.

Conditions

  • Pelvic Organ Prolapse

Sponsors & Collaborators

Principal Investigators

  • Johnny Yi, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-29
Primary Completion
2020-05-18
Completion
2020-05-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03642054 on ClinicalTrials.gov